Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. NAVN
9. DFTX
10. IBM

Go back to Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1102.08 --0 (-0%)
Previous Close $1102.08    52 Week High $88.16 
Open $1102.08    52 Week Low $67.88 
Day High $1102.08    P/E 255.11 
Day Low $1102.08    EPS $4.32 
Volume 3,795